GoodRx Holdings Inc (GDRX) reports robust growth in adjusted EBITDA and Pharma Manufacturer Solutions revenue, despite facing ...
GoodRx (NASDAQ: GDRX) Q3 2024 Earnings Call Nov 07, 2024, 8:00 a.m. ET ...
GoodRx (NASDAQ:GDRX – Get Free Report) had its price target lowered by Barclays from $10.00 to $6.00 in a research note ...
In a report released today, Jailendra Singh from Truist Financial maintained a Hold rating on GoodRx Holdings (GDRX – Research Report), ...
On Monday, Goodrx Holdings Inc (GDRX) stock saw a modest uptick, ending the day at $4.89 which represents no change from the prior close of of $4.89. The stock opened at $4.98 and touched a low of $4.
Raymond James has recently raised Goodrx Holdings Inc (GDRX) stock to Strong Buy rating, as announced on August 9, 2024, according to Finviz. Earlier, on May 23, 2024, RBC Capital Mkts had raised the ...
Harrow (HROW) stock plunged 20% post-market after the eye care drugmaker’s Q3 earnings report missed Street estimates on the ...
Deutsche Bank analyst George Hill lowered the firm’s price target on GoodRx (GDRX) to $8 from $9 and keeps a Hold rating on the shares post the Q3 report. The views and opinions expressed herein ...
December S&P 500 E-Mini futures (ESZ24) are up +0.27%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.33% this morning, extending their post-Election Day gains, while investors looked ahead ...